Advances in the treatment of transplant-eligible and ineligible multiple myeloma

Advances in the treatment of transplant-eligible and ineligible multiple myeloma

Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-FarberПодробнее

Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-Farber

Should You Get a Stem Cell Transplant for Multiple Myeloma? What Patients Need to Know!Подробнее

Should You Get a Stem Cell Transplant for Multiple Myeloma? What Patients Need to Know!

Multiple Myeloma - 2023 Best of Hematology ConferenceПодробнее

Multiple Myeloma - 2023 Best of Hematology Conference

The Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma, Dana-Farber Cancer InstituteПодробнее

The Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma, Dana-Farber Cancer Institute

Paul Richardson | EBMT 2019 | Treatment options for transplant ineligible patients with NDMMПодробнее

Paul Richardson | EBMT 2019 | Treatment options for transplant ineligible patients with NDMM

Living Well with Myeloma: MGUS, Smoldering Myeloma, and Newly DiagnosedПодробнее

Living Well with Myeloma: MGUS, Smoldering Myeloma, and Newly Diagnosed

Dr. Nooka on Treatment Options for Transplant-Eligible and -Ineligible Multiple MyelomaПодробнее

Dr. Nooka on Treatment Options for Transplant-Eligible and -Ineligible Multiple Myeloma

Multiple Myeloma: A Pathway to Better OutcomesПодробнее

Multiple Myeloma: A Pathway to Better Outcomes